The National Directorate of Health Surveillance informs that, in view of the warning issued by the EMA, the Spanish Agency of Medicines and other International Regulatory Agencies, in a preventive manner and considering that this situation represents a health risk, this Ministerial Dependency provides for the suspension of commercialization, placing in quarantine, market recall and subsequent destruction of the drug lots listed in the attachment for the active ingredient Valsartan alone or in association with another drug, from the company ZHEJING HUAHAI, Lindai, China,

More information by the link: https://www.mspbs.gov.py/dnvs/15387/comunicado-dnvs-dg-n-0218.html